Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy

This study has been completed.
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Rockefeller University
Information provided by:
Memorial Sloan Kettering Cancer Center Identifier:
First received: June 17, 2008
Last updated: April 19, 2011
Last verified: April 2011